Some caveats as we seek to identify and harness the therapeutic effects of CBD:
- Although CBD is not innately psychoactive, does not cause a high, has no known lethal dose, is non-toxic, and exhibits no abuse potential, it is still on Schedule I of the Controlled Substances Act because CBD in its natural form is a component of the cannabis plant. Therefore, CBD derived from cannabis grown in the United States or elsewhere is still considered illegal by the federal government.
- The amount of CBD present is not the only factor influencing the efficacy of a particular cannabis-based medicine. The ratio of CBD to THC may be as or more important. Terpenoid and flavonoid content are also extremely important.
- It’s tempting to exaggerate the possible benefits of CBD, and important not to raise false hopes.
- Marijuana prohibitionists will try to exploit the news about CBD to further stigmatize high THC cannabis, casting The High Causer—THC—as the bad cannabinoid and CBD as the good cannabinoid. Project CBD categorically rejects this dichotomy in defense of whole plant cannabis therapeutics. Scientific studies show that CBD and THC work best in combination and potentiate many of each other’s therapeutic benefits.
- Many analytical labs serving the medical cannabis industry in California and other states have not been properly audited and some may not be providing consistently accurate data.
- Products listed and discussed on this website have not been tested or certified by Project CBD unless otherwise indicated.